Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 30Active not recruiting 11Terminated 6Unknown 5Recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Multiple Myeloma 49Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 13Lymphoma 9Recurrence 7Lymphoma, Non-Hodgkin 7Neoplasms 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 4Neoplasms, Plasma Cell 3Neoplasm, Residual 3Lymphoma, T-Cell, Peripheral 3Smoldering Multiple Myeloma 2Leukemia, Plasma Cell 2Hematologic Neoplasms 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Vitamin D Deficiency 1Peripheral Nervous System Diseases 1Paraproteinemias 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematologic Diseases 1Heart Failure 1Dendritic Cell Sarcoma, Interdigitating 1Corneal Diseases 1Cardiotoxicity 1Blood Protein Disorders 1

Interventions

Dexamethasone 5Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3Lenalidomide 3Ciprofloxacin 3Bortezomib 3pomalidomide 2fludarabine phosphate 2fludarabine 2elotuzumab 2carfilzomib 2Radiotherapy 2Immunoglobulins, Intravenous 2Cyclophosphamide 2Amoxicillin-Potassium Clavulanate Combination 2siltuximab 1selinexor 1nirogacestat 1iberdomide 1daratumumab 1belantamab mafodotin 1Positron-Emission Tomography 1Melphalan 1Interviews as Topic 1Immunoglobulins 1Focus Groups 1Fecal Microbiota Transplantation 1Clonal Hematopoiesis 1Clavulanic Acid 1Chromatin Immunoprecipitation Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Plasma Cell × Lenalidomide × Clear all
NCT06863584 2025-03-07

SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
41 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT05248633 2024-06-05

Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

Peking Union Medical College Hospital

Phase 2 Recruiting
220 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT05573802 2023-10-24

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Hellenic Society of Hematology

Phase 1/2 Recruiting
36 enrolled
Plasma cell

Blood Protein Disorders, Corneal Diseases, Hematologic Diseases, Multiple Myeloma, Neoplasms, Paraproteinemias, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡